Frontiers in Medicine (Sep 2023)

Acute kidney injury in patients with COVID-19 compared to those with influenza: a systematic review and meta-analysis

  • Chiu-Ying Hsiao,
  • Heng-Chih Pan,
  • Heng-Chih Pan,
  • Heng-Chih Pan,
  • Heng-Chih Pan,
  • Vin-Cent Wu,
  • Ching-Chun Su,
  • Tzu-Hsuan Yeh,
  • Min-Hsiang Chuang,
  • Kuan-Chieh Tu,
  • Hsien-Yi Wang,
  • Hsien-Yi Wang,
  • Wei-Chih Kan,
  • Wei-Chih Kan,
  • Chun-Chi Yang,
  • Jui-Yi Chen,
  • Jui-Yi Chen

DOI
https://doi.org/10.3389/fmed.2023.1252990
Journal volume & issue
Vol. 10

Abstract

Read online

BackgroundCOVID-19 and influenza can both lead to acute kidney injury (AKI) as a common complication. However, no meta-analysis has been conducted to directly compare the incidence of AKI between hospitalized patients with COVID-19 and influenza. The objective of our study aims to investigate the incidence and outcomes of AKI among hospitalized patients between these two groups.Materials and methodsA systematic search of PubMed, Embase, and Cochrane databases was conducted from December 2019 to August 2023 to identify studies examining AKI and clinical outcomes among hospitalized patients with COVID-19 and influenza. The primary outcome of interest was the incidence of AKI, while secondary outcomes included in-hospital mortality, recovery from AKI, hospital and ICU stay duration. The quality of evidence was evaluated using Cochrane and GRADE methods.ResultsTwelve retrospective cohort studies, involving 17,618 hospitalized patients with COVID-19 and influenza, were analyzed. COVID-19 patients showed higher AKI incidence (29.37% vs. 20.98%, OR: 1.67, 95% CI 1.56–1.80, p < 0.01, I2 = 92.42%), and in-hospital mortality (30.95% vs. 5.51%, OR: 8.16, 95% CI 6.17–10.80, p < 0.01, I2 = 84.92%) compared to influenza patients with AKI. Recovery from AKI was lower in COVID-19 patients (57.02% vs., 80.23%, OR: 0.33, 95% CI 0.27–0.40, p < 0.01, I2 = 85.17%). COVID-19 patients also had a longer hospital stay (SMD: 0.69, 95% CI 0.65–0.72, p < 0.01, I2 = 98.94%) and longer ICU stay (SMD: 0.61, 95% CI 0.50–0.73, p < 0.01, I2 = 94.80%) than influenza patients. In our study, evidence quality was high (NOS score 7–9), with low certainty for AKI incidence and moderate certainty for recovery form AKI by GRADE assessment.ConclusionCOVID-19 patients had higher risk of developing AKI, experiencing in-hospital mortality, and enduring prolonged hospital/ICU stays in comparison to influenza patients. Additionally, the likelihood of AKI recovery was lower among COVID-19 patients.

Keywords